Within the context of breast cancer diagnosis, standard evaluation involves classification according to the expression levels of key receptors such as estrogen receptor α (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.